Dr. Steven Arthur Meckstroth, MD

Dr. Meckstroth practices at Premier Endoscopy Center - Naples in Naples, Florida.

Dr. Meckstroth's NPI, 1073508123, was assigned on September 14, 2005. Dr. Meckstroth graduated from University of Miami, Miller School of Medicine in 1987. Dr. Meckstroth holds Florida license ME54663.

Dr. Meckstroth's primary practice is Premier Endoscopy Center - Naples, at 1656 Medical Blvd, Ste 201, Naples, FL 34110. The practice phone is (239) 449-4945.

Dr. Meckstroth's primary practice is Premier Endoscopy Center - Naples in Naples, Florida. Dr. Meckstroth is also affiliated with NCH Baker Hospital. The medical group on file is Premier Endoscopy Center. Dmand AI also links Dr. Meckstroth to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meckstroth practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Meckstroth's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Meckstroth is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Meckstroth's licenses on file in 2 states: Florida and Louisiana.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Meckstroth treats.

CMS data shows 5,372 Medicare services from Dr. Meckstroth across 24 procedure codes in 2024, for 1,485 Medicare patients. Medicare paid $441,759 for them.

CMS counts 1,485 Medicare patients who saw Dr. Meckstroth in 2024. The largest group is 75 to 84, with 658 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meckstroth's median patient age at 69, with 52% women.

In 2024, Dr. Meckstroth wrote 1,574 Medicare Part D claims for 492 patients. 77% of them were for generic drugs. CMS names the drug for 1,381 of them, across 26 drugs with 11 or more claims each, at $1,026,652 in total drug cost. In 2023, CMS named 1,710 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Meckstroth for performance year 2024, reported as part of a group. Dr. Meckstroth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meckstroth as offering telehealth. CMS counts 743 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Meckstroth, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Meckstroth.

CMS Open Payments shows 768 general payments to Dr. Meckstroth from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,909.

Dmand AI lists 2 awards for Dr. Meckstroth, most recently CMS Stage 1 2012 in 2012.

Dr. Meckstroth graduated from University of Miami, Miller School of Medicine in 1987.

Dr. Meckstroth is in network with 7 carriers, including Aetna, Cigna and Humana. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.